Mitologics is a biotechnology company specializing in mitochondrial dysfunction and bioenergetic analysis. We offer predictive toxicity and efficacy screening using isolated mitochondria and cultured cells. Our assays, validated on mouse and human liver mitochondria, deliver proven predictive value for human hepatotoxicity. Mitologics also perform MoA studies for oncology, cardiovascular, metabolic, and neurodegenerative research, including customized potency assays for cell and gene therapy.